Table 1.

Characteristics of patients selected in the study.

Patient	Primary	Age	Gender	Prior WBRT?	ECOG	Interval (days)	First Session			Second Session
							Rx Dose (Gy)	Tumor Volume (cc)	Diameter (cm)	Rx Dose (Gy)	Tumor Volume (cc)	Diameter (cm)
1	Melanoma	68	F	No	1	26	13	7.92	2.46	13	3.6	1.59
2	Breast	57	F	Yes	2	41	13	9.95	3.11	13	4.78	2.61
3	NSCLC	61	F	No	0	42	13	7.24	2.67	13	2.32	1.84
4	Breast	68	F	No	3	26	13	13.12	4.15	13	6.7	2.77
							13	9.46	3.26	13	4.83	2.16
							13	7.72	2.9	13	3.48	1.96
5	Melanoma	58	M	No	3	21	13	4.02	2.05	12	2.52	1.48
6	NSCLC	79	F	No	2	51	13	17.07	3.6	13	17.8	3.19
							13	12.72	3.52	13	2.83	2.18
							13	9.44	2.85	13	4.51	2.1
							13	17.36	3.47	13	10.92	2.8
7	Breast	44	F	No	0	21	13	16.18	4.31	13	7.59	3.45
							13	12.45	2.92	13	4.8	2
							13	10.37	3.16	13	5.7	2.64
							13	7.64	2.77	13	3.05	1.92
8	Breast	29	F	No	1	33	13	12.83	3.17	13	4.08	2.2
							13	8.43	2.4	13	4.3	1.99
							13	4.8	2.22	13	0.93	1.45
							13	4.26	2.76	13	0.78	1.16
9	NSCLC	83	F	No	2	46	13	16.55	3.18	13	12.44	2.74
10	Breast	54	F	No	1	28	15	6.9	2.78	13	3.64	2.05
11	NSCLC	80	M	No	1	28	13	20.92	4.17	13	13.2	3.05
12	Breast	48	F	No	1	42	13	9.58	2.72	13	4.23	2.02